August 2026
Added to Dediabetes Aug 29, 2026RCTs
The iLet Bionic Pancreas System was evaluated for its effectiveness in improving glycemia in adults with Type 1 Diabetes, showing significant improvements in average glucose levels and time in range.
Interventions
Usual careiLet Bionic Pancreas system
Outcomes
Average glucose levels measured over 24 hoursDaily glucose averagePercentage of participants achieving average glucose <154 mg/dL+2 more
Added to Dediabetes Aug 29, 2026RCTs
Diabetes remote monitoring program facilitated by cellular-connected glucose meter in adults with poorly controlled type 2 diabetes.
Interventions
Diabetes remote monitoring program (IV/UC)
Outcomes
Reduction in Hemoglobin A1C levelsTreatment satisfaction
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the effectiveness of combination therapy with benazepril and valsartan versus monotherapies in preventing microalbuminuria in type 2 diabetes patients.
Interventions
Benazepril monotherapyCombination therapy with benazepril and valsartanValsartan monotherapy
Outcomes
Incidence of hyperkalemiaIncidence of hypotension in patients on combination therapyTime to progression to microalbuminuria
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the usability and patient satisfaction of telemonitoring devices for individuals with heart failure and type 2 diabetes, finding high daily app usage and moderate satisfaction.
Interventions
Telemedicine care
Outcomes
Average daily CPAP usage in hoursMean number of walking sessions per weekPatient engagement+5 more
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the impact of a telemedicine-supported home-based exercise intervention on V̇O2 peak in older patients with coronary heart disease and type 2 diabetes, finding that exercise duration significantly influenced improvements.
Interventions
Telemedicine-supported home-based exercise intervention
Outcomes
Adherence to Purposeful ExercisePeak Oxygen Uptake ImprovementV̇O2 peak with increased exercise intensity
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the effects of empagliflozin on sympathetic outflows in individuals with type 2 diabetes, finding significant reductions in pulmonary capillary wedge pressure and HbA1c levels.
Interventions
Empagliflozin
Outcomes
Body weightCardiac Norepinephrine Spillover RateDiastolic blood pressure+4 more
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the impact of exercise training during pregnancy on gestational weight gain and other health outcomes. It found a significant reduction in gestational diabetes incidence and systolic blood pressure in the exercise group.
Interventions
Exercise therapy
Outcomes
Diastolic blood pressureGestational diabetes mellitus incidenceGestational weight gain+1 more
Added to Dediabetes Aug 29, 2026RCTs
This study evaluated the safety of semaglutide in patients with type 2 diabetes who were initiating dialysis, revealing notable safety concerns.
Outcomes
All-cause mortalityCardiovascular eventsProportion of participants reaching treatment goals+1 more
Added to Dediabetes Aug 29, 2026RCTs
This study explored user experiences with the CONEMO digital intervention for diabetes patients with depressive symptoms, revealing positive health changes for many participants.
Interventions
CONEMO (Emotional Control in Spanish)
Outcomes
Change in WHO-5 Well-Being Index scoreDepression symptoms reductionGastrointestinal disorders incidence+2 more
Added to Dediabetes Aug 29, 2026RCTs
The study evaluated the effectiveness of the Fit After Baby (FAB) mobile health intervention for postpartum weight loss compared to the Text4baby (T4B) control. FAB showed significant weight loss in unaffected participants at 12 months postpartum.
Interventions
Fit After Baby (FAB)Text4baby (T4B)